Canonical correlation analysis for multi-omics: Application to cross-cohort analysis

By sjmartinez • May 23, 2023

Jiang MZ, Aguet F, Ardlie K, Chen J, Cornell E, Cruz D, Durda P, Gabriel SB, Gerszten RE, Guo X, Johnson CW, Kasela S, Lange LA, Lappalainen T, Liu Y, Reiner AP, Smith J, Sofer T, Taylor KD, Tracy RP, VanDenBerg DJ, Wilson JG, Rich SS, Rotter JI, Love MI, Raffield LM, Li Y; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, TOPMed Analysis Working Group. Canonical correlation analysis for multi-omics: Application to cross-cohort analysis. PLoS Genet. 2023 May 22;19(5):e1010517. doi: 10.1371/journal.pgen.1010517. Epub ahead of print. PMID: 37216410.

Tags: Nephrology, Publications

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy

Rovin BH, Ronco PM, Wetzels JFM, Adler SG, Ayoub I, Zaoui P, Han SH, Dudani JS, Gilbert HN, Patel UD, Manser PT, Jauch-Lembach J, Faulhaber[...]

Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease

Galindo RJ, Soliman D, Cherñavvsky D, Rhee CM. Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease. Diabetologia. 2024 Sep 10. doi:[...]

Effect of Bimagrumab on body composition: a systematic review and meta-analysis

Kanbay M, Siriopol D, Copur S, Hasbal NB, Güldan M, Kalantar-Zadeh K, Garfias-Veitl T, von Haehling S. Effect of Bimagrumab on body composition: a systematic[...]